465 related articles for article (PubMed ID: 11231581)
1. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade.
Pleschka S; Wolff T; Ehrhardt C; Hobom G; Planz O; Rapp UR; Ludwig S
Nat Cell Biol; 2001 Mar; 3(3):301-5. PubMed ID: 11231581
[TBL] [Abstract][Full Text] [Related]
2. MEK inhibition impairs influenza B virus propagation without emergence of resistant variants.
Ludwig S; Wolff T; Ehrhardt C; Wurzer WJ; Reinhardt J; Planz O; Pleschka S
FEBS Lett; 2004 Mar; 561(1-3):37-43. PubMed ID: 15013748
[TBL] [Abstract][Full Text] [Related]
3. MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells.
Planz O; Pleschka S; Ludwig S
J Virol; 2001 May; 75(10):4871-7. PubMed ID: 11312358
[TBL] [Abstract][Full Text] [Related]
4. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Guha S; Lunn JA; Santiskulvong C; Rozengurt E
Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
[TBL] [Abstract][Full Text] [Related]
6. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
7. Effects of MEK inhibitor U0126 on meiotic progression in mouse oocytes: microtuble organization, asymmetric division and metaphase II arrest.
Tong C; Fan HY; Chen DY; Song XF; Schatten H; Sun QY
Cell Res; 2003 Oct; 13(5):375-83. PubMed ID: 14672561
[TBL] [Abstract][Full Text] [Related]
8. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3091-8. PubMed ID: 12202534
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes.
Andrieux L; Langouët S; Fautrel A; Ezan F; Krauser JA; Savouret JF; Guengerich FP; Baffet G; Guillouzo A
Mol Pharmacol; 2004 Apr; 65(4):934-43. PubMed ID: 15044623
[TBL] [Abstract][Full Text] [Related]
10. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo.
Pinto R; Herold S; Cakarova L; Hoegner K; Lohmeyer J; Planz O; Pleschka S
Antiviral Res; 2011 Oct; 92(1):45-56. PubMed ID: 21641936
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.
Anders M; Christian C; McMahon M; McCormick F; Korn WM
Cancer Res; 2003 May; 63(9):2088-95. PubMed ID: 12727824
[TBL] [Abstract][Full Text] [Related]
15. ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf.
Mercer K; Chiloeches A; Hüser M; Kiernan M; Marais R; Pritchard C
Oncogene; 2002 Jan; 21(3):347-55. PubMed ID: 11821947
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
17. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
Lee M
Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo.
Droebner K; Pleschka S; Ludwig S; Planz O
Antiviral Res; 2011 Nov; 92(2):195-203. PubMed ID: 21854809
[TBL] [Abstract][Full Text] [Related]
19. MEK1-ERKs signal cascade is required for the replication of Enterovirus 71 (EV71).
Wang B; Zhang H; Zhu M; Luo Z; Peng Y
Antiviral Res; 2012 Jan; 93(1):110-7. PubMed ID: 22101247
[TBL] [Abstract][Full Text] [Related]
20. Activation of the Raf-1/MEK/Erk kinase pathway by a novel Cdc25 inhibitor in human prostate cancer cells.
Nemoto K; Vogt A; Oguri T; Lazo JS
Prostate; 2004 Jan; 58(1):95-102. PubMed ID: 14673957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
